Butterfly Network (BFLY) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
27 Apr, 2026Voting matters and shareholder proposals
Seven directors are nominated for election to serve one-year terms expiring in 2027.
Ratification of Deloitte & Touche LLP as independent registered public accounting firm for fiscal year ending December 31, 2026 is proposed.
Advisory vote on executive compensation for named executive officers is included.
Proxies may vote on other business that may arise during the meeting or any adjournment.
Board of directors and corporate governance
Board recommends all seven director nominees for election.
Nominees include Joseph DeVivo, Jonathan M. Rothberg, Larry Robbins, Caroll H. Neubauer, Elazer Edelman, S. Louise Phanstiel, and Erica Schwartz.
Executive compensation and say-on-pay
Shareholders are asked to approve, on a non-binding advisory basis, the compensation of named executive officers as disclosed in the proxy statement.
Latest events from Butterfly Network
- Q2 2026 revenue up 39.5% to $32.6M, gross margin 71.4%, and Embedded partnerships drove growth.BFLY
Q2 2026 - Directors elected, auditor ratified, and executive compensation approved with no stockholder questions.BFLY
AGM 2026 - Semiconductor ultrasound tech, AI ecosystem, and licensing drive growth and industry expansion.BFLY
46th Annual William Blair Growth Stock Conference - AI-powered ultrasound and embedded tech drive global growth and financial improvement.BFLY
Bank of America Global Healthcare Conference 2026 - Q1 2026 revenue up 25%, gross margin at 68.9%, and adjusted EBITDA loss narrowed to $6.1M.BFLY
Q1 2026 - Proxy covers director elections, auditor ratification, and executive pay, with founder holding voting control.BFLY
Proxy filing - AI-powered ultrasound and embedded tech drive growth, with 2026 revenue seen at $117M-$121M.BFLY
TD Cowen 46th Annual Health Care Conference - Record Q4 revenue, margin gains, and positive cash flow set stage for 2026 growth.BFLY
Q4 2025 - AI-driven chip innovation, global expansion, and new partnerships fuel strong growth and revenue.BFLY
44th Annual J.P. Morgan Healthcare Conference